General Proximity
PrivateLast Round
Strategic
May 4, 2026
Total Funding Raised
$16M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
General Proximity is a biotechnology company that develops next-generation induced-proximity medicines using its proprietary OmniTAC platform to target previously undruggable proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
General Proximity Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
General Proximity Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 4, 2026 | ||||
| Seed | Jan 3, 2025 |
General Proximity Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| age1 | Seed |
| Y Combinator | Seed |
| Wilson Sonsini Goodrich & Rosati | Seed |
| Healthspan Capital | Seed |
| LifeSpan Vision Ventures | Seed |
| Modi Ventures | Seed |
| Felicis Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
Raised capital from Daewoong Pharmaceutical and FreeMind Group.
- Nov 12, 2025
Partnered with Daiichi Sankyo to apply OmniTAC discovery platform to oncology programs.
General Proximity Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about General Proximity's valuation, stock price, and market status.